Trial
NCT03067974
Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Arizona
Collaborators
—
Condition
Failed Moderate Sedation During Procedure
Intervention
Ketamine Hcl 100Mg/Ml Inj
Why stopped
Initial results did not show benefit.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-28